Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kukje Pharma CoXKRX:002720 -0.59%66 Pretax Margin % is 4.51% as of Jun. 2026, which is 110% above its 10-year median of 2.15. GuruFocus rates XKRX:002720 with a GF Score™ of 66/100 and a GF Value™ of ₩5,625.96 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 960 Drug Manufacturers companies, Kukje Pharma Co ranks worse than 59.69% on this metric.
The historical rank and industry rank for Kukje Pharma Co's Pretax Margin % or its related term are showing as below:
XKRX:002720'
s Pretax Margin % Range Over the Past 10 Years
Min: -4.93 Med: 2.15 Max: 4.29
Current: 3.13
XKRX:002720's Pretax Margin % is ranked worse than 59.69% of 960
companies
in the Drug Manufacturers industry
Industry Median: 7.155
vs XKRX:002720: 3.13
Kukje Pharma Co (XKRX:002720) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Kukje Pharma Co Pretax Margin % Related Terms
Kukje Pharma Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Kukje Pharma Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kukje Pharma Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kukje Pharma Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kukje Pharma Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Kukje Pharma Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kukje Pharma Co (XKRX:002720) has a Pretax Margin % of 4.51% as of Jun. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Kukje Pharma Co and its competitors. This is 110% above median its historical median of 2.15. According to the industry distribution chart, Kukje Pharma Co ranks #573 out of 960 companies in the Drug Manufacturers industry, placing it in the top 59.7%.
Is Kukje Pharma Co's Pretax Margin % too high?
Kukje Pharma Co's current Pretax Margin % of 4.51% is 110% above median its 10-year median of 2.15. The Drug Manufacturers industry median Pretax Margin % is 7.16. Kukje Pharma Co's value of 4.51% is 37% below this industry median. Based on the distribution chart, Kukje Pharma Co ranks #573 out of 960 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Kukje Pharma Co has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kukje Pharma Co's Pretax Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kukje Pharma Co ranks #573 out of 960 companies for Pretax Margin %. This places Kukje Pharma Co in the lower half of its industry. The industry median Pretax Margin % is 7.16. Kukje Pharma Co's value of 4.51% is 37% below this benchmark. While the company's 10-year median is 2.15 vs. the industry median of 7.16, Kukje Pharma Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.16, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kukje Pharma Co's current Pretax Margin % of 4.51% is 37% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Kukje Pharma Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kukje Pharma Co's current Pretax Margin % is 4.51%, which is 110% above median its own 10-year median of 2.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kukje Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Kukje Pharma Co (XKRX:002720) is currently considered Possible Value Trap. The stock's GF Value™ is ₩5,625.96, compared to a current price of ₩3,395.00 — trading 39.7% below its estimated fair value. The current Pretax Margin % is 4.51%, which is 110% above median its 10-year median of 2.15 and 37% below the Drug Manufacturers industry median of 7.16. Kukje Pharma Co's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Kukje Pharma Co (XKRX:002720), the current Pretax Margin % is 4.51% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kukje Pharma Co (XKRX:002720) Overvalued in 2026?
Based on GuruFocus' analysis, Kukje Pharma Co stock appears to be undervalued.
The current stock price of ₩3,395.00 is trading 39.7% below its estimated GF Value™ of ₩5,625.96.
GuruFocus considers Kukje Pharma Co to be Possible Value Trap.
Key valuation signals for XKRX:002720:
Pretax Margin %: 4.51% (110% above median its 10-year median of 2.15)
GF Value™: ₩5,625.96 vs. price of ₩3,395.00 (39.7% below fair value)
Industry Position: 37% below the Drug Manufacturers median (#573 of 960)
No single metric tells the full story. See the XKRX:002720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kukje Pharma Co Ltd is engaged in the manufacturing and sales of pharmaceutical products, and it handles over-the-counter and prescription drugs such as Q-Allon eye drops, Letium tablets, Ezerova tablets, Colencia soft capsules, and International Cephazedon injection.
66GF Score
Get the complete analysis for XKRX:002720
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:002720 has been successfully added to your 
